Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Health Choice Alliance, LLC v. Eli Lilly and Company, Inc. et al
Case Number:
5:17-cv-00123
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Arnold & Porter
- Faegre Drinker
- Hinshaw & Culbertson
- Howry Breen
- Jones Day
- Lanier Law Firm
- Lynn Pinker
- McDermott Will & Emery
- McKool Smith
- Morgan Lewis
- Noroozi PC
- Patton Tidwell
- Reese Marketos
- Siebman Law
- Ward Smith
Companies
Sectors & Industries:
-
September 30, 2019
DOJ Wins Bids To End FCA Suits Targeting Eli Lilly, Bayer
The federal government's interest in conserving resources is a good enough reason for the U.S. Department of Justice to torpedo whistleblower False Claims Act suits, a Texas federal judge has ruled in axing FCA cases accusing Eli Lilly and Bayer of funneling kickbacks to doctors.
-
May 17, 2019
Texas Judge Backs Broad DOJ Authority To End FCA Suits
A Texas federal judge on Thursday recommended the dismissal of False Claims Act suits accusing Eli Lilly and Bayer of providing kickbacks to doctors in the form of various assistance services, saying the U.S. Department of Justice has "virtually unfettered" dismissal authority in whistleblower FCA cases.
-
April 17, 2019
DOJ Dismissal Power Looking Wobbly In FCA Cases
The U.S. Department of Justice's newly launched campaign to shrink its False Claims Act docket has hit surprising turbulence as federal judges scrutinize the DOJ's willingness to look the other way on alleged fraud and its disparagement of a company that specializes in bringing FCA cases.
-
January 23, 2019
FCA Co. Torches DOJ Effort To Scuttle Suits
A company that specializes in bringing False Claims Act cases has launched a scorched-earth attack on the U.S. Department of Justice for seeking dismissal of nearly a dozen suits it filed, accusing the DOJ of trying to "legalize certain kickbacks" to doctors from drugmakers.
-
December 18, 2018
DOJ Aims Torpedo At 11 FCA Kickback Suits
In a striking development, the U.S. Department of Justice is seeking to terminate 11 False Claims Act cases involving a new theory that patient assistance services supplied by drugmakers are unlawful kickbacks.
-
August 14, 2018
Drug Kickback Suit Against Eli Lilly Dismissed For Now
A Texas federal judge gave Eli Lilly and Co. and four health care companies a reprieve from a whistleblower lawsuit alleging they conspired to offer kickbacks to boost prescriptions of insulin and osteoporosis drugs, finding that a health care research organization's allegations were too vague but leaving the door open for the group to try again.